SNODGRASS H. RALPH 4
4 · VistaGen Therapeutics, Inc. · Filed Oct 22, 2019
Insider Transaction Report
Form 4
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2019-10-21+175,000→ 175,000 totalExercise: $1.41Exp: 2029-10-21→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]25% of the Shares subject to the Option shall vest on date of grant October 21, 2019, and 1/24th of the remaining Shares subject to the Option shall vest on each monthly anniversary of the grant date thereafter.